Evonik plans restructuring phase two
Evonik Industries plans to launch the second phase of its restructuring programme in 2027. The overhaul includes the planned sales of subsidiaries Oxeno and Syneqt.
Xurve View
Insights:
Xurve View

Evonik Industries will launch the second phase of its restructuring programme in 2027, cutting jobs and pursuing the sale of two business units. The overhaul follows an initial 2024 restructuring aimed at reducing the workforce by over a fifth. The specialty chemicals producer operates across Germany and continues to realign its core operations.









